Evolving Frontiers in Cancer Treatment
Kilder
- Nature: The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types - Nature
- Nature: Prime editor-based high-throughput screening reveals functional synonymous mutations in human cells - Nature
- Nature: A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature
- Statnews: Nuvalent says its ROS1-targeted drug shrank lung tumors in patients who failed other options - STAT
- Bioworld: Moderna expands mRNA tech to latent viruses, cancer, rare disease - BioWorld MedTech
- Bioworld: Revmed goes global with $2B in capital for RAS(ON) inhibitors - BioWorld MedTech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.